Pluristem Therapeutics (Nasdaq: PSTI) announced that its licensee, United Therapeutics Corporation (Nasdaq: UTHR), has completed the dosing of the first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE